bioAffinity Technologies, Inc. Warrant closed at $0.26 on Sep 28, down 18.75%, 62.9% below its highest close since Sep 1. Volume of 2.3K shares was 0.13× its 20-day average (below normal).
Split-adjusted performance: +246.2% over one month.
In the quarter ended Jun 30, 2026, revenue was $1.51M, up 19.0% from a year earlier, with a net margin of -222.8%.
Short interest was 445 shares at the Sep 15 settlement, down 85.9% from the prior report (1.0 days to cover).
No recent articles focused on bioAffinity Technologies, Inc. Warrant.
Quick answers
What does bioAffinity Technologies, Inc. Warrant do?
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung.
What is BIAFW's market cap?
$416.33K, based on the Sep 28 close of $0.26.
What sector is BIAFW in?
Technology, in the R&D — Physical & Biological Sciences industry.
About bioAffinity Technologies, Inc. Warrant
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
